FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,307 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0190 | 00053-0190-19 | — |
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0200 | 00053-0200-20 | — |
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0210 | 00053-0210-21 | — |
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0220 |
| — |
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0230 | 00053-0230-23 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0240 | 00053-0240-24 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0250 | 00053-0250-25 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0260 | 00053-0260-26 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0270 | 00053-0270-27 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0280 | 00053-0280-28 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0290 | 00053-0290-29 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0300 | 00053-0300-30 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0310 | 00053-0310-31 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0320 | 00053-0320-32 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0330 | 00053-0330-33 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0340 | 00053-0340-34 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0350 | 00053-0350-35 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0360 | 00053-0360-36 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0370 | 00053-0370-37 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0380 | 00053-0380-38 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0390 | 00053-0390-39 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0400 | 00053-0400-40 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0410 | 00053-0410-41 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0420 | 00053-0420-42 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0430 | 00053-0430-43 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0440 | 00053-0440-44 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0450 | 00053-0450-45 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0460 | 00053-0460-46 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0470 | 00053-0470-47 | — |
|---|
| Hemgenixetranacogene dezaparvovec | — | Kit | CSL Behring | BLA | 0053-0480 | 00053-0480-48 | — |
|---|
| Hemiclorchlorthalidone | Chlorthalidone 12.5 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | NDA | 50742-285 | 50742-0285-3050742-0285-90 | — |
|---|
| Hemlibraemicizumab | Emicizumab 30 mg/mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-920 | 50242-0920-01 | — |
|---|
| Hemlibraemicizumab | Emicizumab 60 mg/.4mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-921 | 50242-0921-01 | — |
|---|
| Hemlibraemicizumab | Emicizumab 105 mg/.7mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-922 | 50242-0922-01 | — |
|---|
| Hemlibraemicizumab | Emicizumab 150 mg/mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-923 | 50242-0923-01 | — |
|---|
| Hemlibraemicizumab | Emicizumab 12 mg/.4mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-927 | 50242-0927-01 | — |
|---|
| Hemlibraemicizumab | Emicizumab 300 mg/2mL | Injection, SolutionSubcutaneous | Genentech, Inc. | BLA | 50242-930 | 50242-0930-01 | — |
|---|
| Hemmorex-HChydrocortisone acetate | Hydrocortisone acetate 25 mg/1 | SuppositoryRectal | Laser Pharmaceuticals, LLC | Unapproved drug (other) | 16477-201 | 16477-0201-1216477-0201-2416477-0201-99 | — |
|---|
| Hemmorex-HChydrocortisone acetate | Hydrocortisone acetate 30 mg/1 | SuppositoryRectal | Laser Pharmaceuticals, LLC | Unapproved drug (other) | 16477-202 | 16477-0202-12 | — |
|---|
| Hemofil Mantihemophilic factor human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3940 | 00944-3940-02 | — |
|---|
| Hemofil Mantihemophilic factor human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3942 | 00944-3942-02 | — |
|---|
| Hemofil Mantihemophilic factor human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3944 | 00944-3944-02 | — |
|---|
| Hemofil Mantihemophilic factor human | — | Kit | Takeda Pharmaceuticals America, Inc. | BLA | 0944-3946 | 00944-3946-02 | — |
|---|
| Hemoforceurtica urens, ferrum muriaticum, aranea diadema, aurum metallicum, cinchona officinalis, cobaltum gluconate, phosphorus | Urtica urens whole 3 [hp_X]/mL + 6 more ingredients | LiquidOral | BioActive Nutritional, Inc. | Unapproved homeopathic | 43857-0025 | 43857-0025-01 | — |
|---|
| Hemorrhoidaesculus hipp, hamamelis, aloe, calc phos, carbo an, carbo veg, lachesis, lycopodium, muriaticum ac, nitricum ac, nux vom, paeonia, ratanhia, sepia, sulphur | Horse chestnut 30 [hp_C]/mL + 14 more ingredients | LiquidOral | Natural Creations, Inc | Unapproved homeopathic | 43406-0681 | 43406-0681-01 | — |
|---|
| Hemorrhoid and Fissureglycerin 6%,lidocaine 4%,ectoin 0.12% | Ectoin .0012 g/g + 2 more ingredients | OintmentTopical | FlexiGo Inc | OTC monograph drug | 85524-2602 | 85524-2602-0285524-2602-0485524-2602-06 | — |
|---|
| Hemorrhoid Anestheticmineral oil, petrolatum, phenylephrine hcl | Mineral oil .14 g/g + 2 more ingredients | OintmentTopical | Universal Distribution Center LLC | OTC monograph drug | 52000-057 | 52000-0057-02 | — |
|---|
| Hemorrhoid Control Extra Strengthhamamelis virginiana root bark/stem bark and horse chestnut | Hamamelis virginiana root bark/stem bark 8 [hp_X]/1000mL; Horse chestnut 8 [hp_X]/1000mL | Solution/ dropsTopical | Forces of Nature | Unapproved homeopathic | 51393-6447 | 51393-6447-0151393-6447-0351393-6447-05 | — |
|---|
| Hemorrhoid Cream | Zinc oxide 10 g/100g + 3 more ingredients | CreamCutaneous | Henan Shouerkang Health Industry Co., Ltd | OTC monograph drug | 85056-003 | 85056-0003-0185056-0003-0285056-0003-03+2 more | — |
|---|
| Hemorrhoid Drops 2028hemorrhoid drops | Horse chestnut 2 [hp_X]/59mL + 11 more ingredients | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-2028 | 63083-2028-02 | — |
|---|